Magnesium vs Melatonin
Both are commonly discussed for sleep. Magnesium and Melatonin both have moderate evidence — Magnesium edges ahead on research volume (20 vs 20 studies referenced).
Evidence last reviewed May 2026
Melatonin recommends stacking with Magnesium: Magnesium supports GABAergic relaxation and sleep quality, potentially complementing melatonin's circadian signaling role for a broader sleep-supportive effect.
Evidence
🟡Moderate Evidence
🟡Moderate Evidence
Research says
Research agrees
Research agrees
Expert mentions
315
4 recommend
216
3 recommend
Studies
20
referenced
20
referenced
Study dose
200–400mg
Studies and expert sources consistently reference 200–400 mg of elemental magnesium daily; the required capsule dose varies significantly by form, as elemental magnesium content differs — for example, magnesium glycinate is roughly 14% elemental magnesium, meaning a 400 mg capsule delivers only ~56 mg elemental magnesium.
0mg
The body's endogenous nightly output is approximately 0.1–0.3 mg; studied supplemental doses range from 0.5 mg (sufficient for phase-shifting per expert consensus) up to 10 mg (common OTC doses), though lower doses of 0.5–1 mg are considered more physiologically appropriate for general sleep onset by clinical experts, as higher doses may blunt receptor sensitivity over time.
Best timing
EveningWith food
EveningEmpty stomach
Who recommends
Caution
Generally safe
Generally safe
Magnesium
Key findings
- ·A strong-quality meta-analysis found oral magnesium supplementation improved sleep outcomes in older adults with insomnia, partially supporting claims about magnesium's role in sleep quality and onset.
- ·A strong-quality meta-analysis found magnesium supplementation positively affected glucose metabolism parameters in people with or at risk of type 2 diabetes, suggesting metabolic benefits in at-risk populations.
- ·Moderate-quality reviews support a role for magnesium in migraine prevention and in cardiovascular and cardiometabolic health, though causality and effect sizes require further confirmation.
Evidence gaps
- ·Most evidence comes from older adults or clinically deficient populations; it remains unclear whether magnesium supplementation benefits healthy individuals with adequate baseline magnesium levels.
- ·Form-specific clinical outcome data (e.g., glycinate, threonate, malate) is largely absent from high-quality trials, making it impossible to definitively recommend one form over another for specific outcomes like sleep or cognition.
Melatonin
Key findings
- ·Melatonin is consistently characterized across multiple reviews as a chronobiotic hormone — a darkness signal produced by the pineal gland — not a sedative or sleep drug.
- ·A meta-analysis on dietary supplements found melatonin associated with improvements in sleep quality outcomes, representing one of the stronger evidence-based applications.
- ·A systematic review and meta-analysis supports melatonin use in ICU patients, suggesting potential benefits in this specific clinical population.
Evidence gaps
- ·Long-term safety and efficacy data for melatonin supplementation in healthy adults and children are largely absent from the reviewed literature, leaving many dosing and duration questions unanswered.
- ·Most reviewed studies are narrative reviews or general overviews rather than large, well-controlled RCTs, making it difficult to establish causality or optimal dosing protocols for specific conditions.